DIEBOLD NIXDORF, Inc
DBD· NYSE
Filed Feb 25, 2025 · 10-K · 56 days after period end · 0000028823-25-000022
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $988.90M | $968.80M | $1.06B | $1.11B |
| Net Income | $5.60M | -$149.30M | -$38.30M | -$51.20M |
| EPS Diluted | — | — |
DIEBOLD NIXDORF, Inc · CIK 28823 · Engraved from SEC EDGAR
| — |
| -$0.66 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2024 · filed Feb 25, 2025 · 56 d after period end